Skip to content

Individualized Fortification of Human Milk for Infants Born ≤ 1250 g (MaxiMoM-InForM)

MaxiMoM: Individualized Fortification of Human Milk for Infants Born ≤ 1250 g; a Three Arm Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05308134
Enrollment
615
Registered
2022-04-01
Start date
2021-11-11
Completion date
2027-10-01
Last updated
2026-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Very Low Birth Weight Infant

Brief summary

Very low birth weight infants have increased nutritional needs. Extra nutrients are added to their human milk feeds to help improve their nutritional status, growth and neurodevelopment. Standard fortification of human milk is routine in most neonatal units in North America, but despite the added nutrients, infants are often discharged from hospitals with poor growth, and their neurodevelopment remains suboptimal. Two individualized fortification methods, target and BUN adjustable, have been proposed to improve the nutrient supply to infants. However, there is currently insufficient evidence to support the implementation of individualized fortification or one method over the other. Therefore, this study will randomly assign very low birth weight infants to receive feeds fortified according to standard, target or BUN adjustable fortification methods until the end of the feeding intervention. Feedings will be prepared in milk preparation rooms to ensure caregivers and outcomes assessor remain blinded to feeding allocation. Growth, morbidities, and nutrient intakes will be determined throughout hospitalization and skinfolds assessed at 36 weeks. At 4 months CA, growth and body composition will be determined by air displacement plethysmography on a subset of infants. Neurodevelopment will be assessed using the Bayley Scales of Infant and Toddler Development, at 18-24 months CA.

Detailed description

The end of the feeding intervention is defined as: the infant is 36+0 weeks CA, is discharged home, or receives two oral feeds daily for three consecutive days without top-up. The exception to the 36+0 weeks intervention end-date is in the situation where an infant remains hospitalized but has not completed at least four weeks of the feeding intervention (i.e. 4 weeks following Study Day 1).

Interventions

Standard fortification assumes that the nutrient content of human milk is constant and involves use of a standard fixed dose of multi-nutrient fortifier and as appropriate nutrient modulars.

Target fortification involves use of a multi-nutrient fortifier as well as weekly analysis of energy and macronutrients of human milk and subsequent addition of fat and protein modulars if needed.

OTHERBUN adjustable fortification

BUN (blood urea nitrogen) adjustable fortification involves use of a multi-nutrient fortifier as well as weekly BUN tests and subsequent addition of a protein modular according to a prescribed algorithm.

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 21 Days
Healthy volunteers
No

Inclusion criteria

* ≤1250 g birth weight or Gestational Age \<30+0 weeks and \<1500 g birth weight. * Parental/guardian consent to participate. * Consent for the use of pasteurized donor milk if mother's milk is not available.

Exclusion criteria

* Infant received fortifier or formula before Study Day 1. * Study Day 1 anticipated to occur after postnatal day 21. * Infants with congenital or chromosomal anomalies or brain injury that may affect growth or neurodevelopment. * Enrollment in any other clinical study affecting nutritional management during the feeding intervention. * Reasonable potential that the infant will be transferred to a NICU where the study protocol will not be continued before they have completed at least 4 weeks of the feeding intervention.

Design outcomes

Primary

MeasureTime frameDescription
Cognitive Composite Score18-24 months corrected ageBayley Scales of Infant and Toddler Development

Secondary

MeasureTime frameDescription
Language Composite Score18-24 months CABayley Scales of Infant and Toddler Development
Motor Composite Score18-24 months CABayley Scales of Infant and Toddler Development
Weight Gain during the interventionStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs firstChange in z-score
Length gain during the interventionStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs firstChange in z-score
Head circumference gain during the interventionStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs firstChange in z-score
Body composition at the end of the intervention36 weeks corrected ageSkinfolds
Serious MorbidityStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs firstComposite of death, NEC, late onset sepsis, chronic lung disease or severe retinopathy of prematurity (ROP)
Health EconomicsStudy Day 1 to 36 weeks corrected age or hospital discharge, whichever occurs firstTotal cost incurred for in-hospital care
Weight at follow-up4 months corrected agez score
Length at follow-up4 months corrected agez score
Head Circumference at follow-up4 months corrected agez score
Body composition at follow-up (approximated)4 months corrected ageSkinfolds
Body composition at follow-up (direct measurement)4 months corrected ageAir displacement plethysmography

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORDeborah O'Connor, PhD RD

The Hospital for Sick Children

PRINCIPAL_INVESTIGATORSharon Unger, MD

Sinai Health System

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 5, 2026